S. Weller

发表

Pharmacokinetics of Acyclovir and Its Metabolites in Cerebrospinal Fluid and Systemic Circulation after Administration of High-Dose Valacyclovir in Subjects with Normal and Impaired Renal Function

D. Haas, James P. Smith, S. Weller, 2009, Antimicrobial Agents and Chemotherapy.

Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

S. Soong, D. Powell, W. Gruber, 2001, Pediatrics.

Bioequivalence of a Dolutegravir, Abacavir, and Lamivudine Fixed-Dose Combination Tablet and the Effect of Food

S. Piscitelli, S. Weller, B. Wynne, 2014, Journal of acquired immune deficiency syndromes.

Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.

R. Jacobs, J. van der Walt, S. Weller, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Review of the Pharmacokinetics of Abacavir

S. Weller, G. E. Pakes, G. Yuen, 2008, Clinical pharmacokinetics.

Pharmacokinetics and pharmacodynamics of a new cardiotonic vasodilator agent, 349U85, in normal subjects

M. Harrison, R. Welch, S. Weller, 1994, Clinical pharmacology and therapeutics.

Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With In ﬂ uenza: An Open-label, Multicenter, Single-Arm, Phase II Study

D. Brealey, J. Lorente, P. Yates, 2014 .

Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulations in patients infected with human immunodeficiency virus

J. Bartlett, S. Weller, H. Gallis, 1989, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of Zanamivir following Intravenous Administration to Subjects with and without Renal Impairment

S. Weller, Lori S. Jones, Y. Lou, 2013, Antimicrobial Agents and Chemotherapy.

Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells.

G. Rosner, W. Plunkett, M. Keating, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy

S. Weller, M. Smiley, M. Schultz, 1996, Antimicrobial agents and chemotherapy.

Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study

D. Brealey, J. Lorente, P. Yates, 2013, The Journal of infectious diseases.

Comparable aciclovir exposures produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients.

M. Höglund, P. Ljungman, S. Weller, 2001, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of the acyclovir pro‐drug valaciclovir after escalating single‐and multiple‐dose administration to normal volunteers

D. Cederberg, T. Burnette, S. Weller, 1993, Clinical pharmacology and therapeutics.

Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.

J. Hauth, W. Andrews, S. Weller, 1998, American journal of obstetrics and gynecology.

Oral Valaciclovir - Increased Acyclovir Bioavailability in Different Patient Populations:

S. Weller, J. Soul-Lawton, L. Wang, 1994 .

Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease

M. Jacobson, S. Weller, J. Gallant, 1994, Antimicrobial Agents and Chemotherapy.

The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082)

W. Parks, S. Weller, Y. Bryson, 1993 .

The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group.

W. Parks, S. Weller, Y. Bryson, 1993, American journal of obstetrics and gynecology.

Combination Therapy with Zidovudine and Didanosine Compared with Zidovudine Alone in HIV-1 Infection

P. Volberding, A. Collier, L. Corey, 1993, Annals of Internal Medicine.

Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.

S. Pelton, J. Modlin, S. Weller, 1993, The Journal of pediatrics.

Pharmacokinetics of acyclovir suspension in infants and children

M. Levin, J. Connor, S. Weller, 1987, Antimicrobial Agents and Chemotherapy.

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation

S. Piscitelli, S. Weller, B. Wynne, 2016, European Journal of Clinical Pharmacology.

Population Pharmacokinetics and Pharmacodynamic Modeling of Abacavir (1592U89) from a Dose-Ranging, Double-Blind, Randomized Monotherapy Trial with Human Immunodeficiency Virus-Infected Subjects

S. Weller, D. Stein, Y. Lou, 2000, Antimicrobial Agents and Chemotherapy.

An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children.

G. Leverger, D. Nadal, S. Weller, 2002, The Journal of infectious diseases.

Evaluation of Pharmacokinetic Interactions After Oral Administration of Mycophenolate Mofetil and Valaciclovir or Aciclovir to Healthy Subjects

C. Garret, S. Weller, O. Bourdon, 2004, Clinical pharmacokinetics.

Erratum to: A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors

G. Shapiro, P. LoRusso, S. Swann, 2013, Investigational New Drugs.

A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors

G. Shapiro, P. LoRusso, S. Swann, 2012, Investigational New Drugs.

A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors

R. Plummer, J. Botbyl, M. Scheulen, 2012, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment

S. Piscitelli, S. Weller, B. Wynne, 2013, European Journal of Clinical Pharmacology.

A Comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors

P. Bonate, P. LoRusso, R. Kurzrock, 2012, Investigational New Drugs.